Know Labs, Inc. (NYSEAMERICAN:KNW – Get Free Report) rose 3.8% during mid-day trading on Friday. The company traded as high as $2.17 and last traded at $2.1390. 612,050 shares traded hands during trading, a decline of 86% from the average session volume of 4,376,964 shares. The stock had previously closed at $2.06.
Know Labs Price Performance
The stock has a market capitalization of $16.04 million, a PE ratio of -0.33 and a beta of 1.83. The stock’s fifty day moving average is $2.14 and its 200-day moving average is $2.14.
Know Labs Company Profile
Know Labs, Inc is a biotechnology and medical technology company developing noninvasive diagnostic and monitoring technologies. The company’s platform uses electromagnetic spectroscopy, which it calls Bio-RFID, to analyze the molecular composition of substances without requiring traditional blood draws or chemical reagents.
Know Labs has focused primarily on noninvasive glucose monitoring for people with diabetes. Its product-development efforts have included wearable devices such as the KnowU and UBand, which are designed to collect sensor readings and potentially provide continuous glucose measurements.
Recommended Stories
- Five stocks we like better than Know Labs
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Know Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Know Labs and related companies with MarketBeat.com's FREE daily email newsletter.
